The roles of vitamin D in skeletal muscle: Form, function, and metabolism

Endocrine Reviews

Volumn 34, Issue 1, 2013, Pages 33-83

  Girgis, Christian M ^a,b   Clifton Bligh, Roderick J ^b,c   Hamrick, Mark W ^d   Holick, Michael F ^e   Gunton, Jenny E ^a,b,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b University of Sydney   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^f WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEHYDROCHOLESTEROL; ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM; CAVEOLIN 1; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; CYTOCHROME P450; INSULIN; INTERLEUKIN 6; LEGUMAIN; MEGALIN; MESSENGER RNA; OXYGENASE; PHOSPHATE; PHOSPHOLIPID; VITAMIN D;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CYTOSKELETON; ENZYME ACTIVITY; FALLING; FORCED SWIMMING TEST; FUNCTIONAL ASSESSMENT; GENE ACTIVITY; GLUCOSE TRANSPORT; HUMAN; IMMUNOPRECIPITATION; INSULIN SENSITIVITY; MITOCHONDRION; MOLECULAR INTERACTION; MORPHOLOGY; MOTOR COORDINATION; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOBLAST; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VITAMIN D DEFICIENCY;

ADULT; ANIMALS; CALCIUM; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DISEASES; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84874368830     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2012-1012     Document Type: Review

References (390)

1. Moreno LA, Valtueña J, Pérez-López F, González-Gross M 2011 Health effects related to low vitamin D concentrations: beyond bone metabolism. Ann Nutr Metab 59: 22-27.
2. Christakos S, DeLuca HF 2011 Vitamin D: is there a role in extraskeletal health. Endocrinology 152:2930-2936.
3. Holick MF 2007 Vitamin D deficiency. N Engl J Med 357: 266-281.
4. Thacher TD, Clarke BL 2011 Vitamin D insufficiency. Mayo Clin Proc 86:50-60.
5. van Schoor NM, Lips P 2011 Worldwide vitaminDstatus. Best Pract Res Clin Endocrinol Metab 25:671-680.
6. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J 2009 Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20: 1807-1820.
7. Forrest KY, Stuhldreher WL 2011 Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31: 48-54.
8. Ginde AA, Liu MC, Camargo Jr CA 2009 Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169:626-632.
9. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N 2010 IOF position statement: vitaminDrecommendations for older adults. Osteoporos Int 21:1151-1154.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM 2011 Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911-1930.
11. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA 2011 The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58.
12. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS 2012 The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33:456-492.
13. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, DemayM2008 Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726-776.
14. Monderson F 2007 The majesty of Egyptian gods and temples: a book of Egyptian poems. Bloomington, IN: Author-House.
15. Mayer E 1932 The curative value of light: sunlight and sun lamp in health and disease. Whitefish, MT: Kessinger Publishing.
16. Spellberg AE 1952 Increase of athletic effectiveness by systematic ultraviolet irradiation. [In German]. Strahlentherapie 88:567-570.
17. Gorkin Z GM, Teslenko NE 1938 The effect of ultraviolet irradiation upon training for 100m sprint. Fiziol Zh USSR 25:695-701 (Russian).
18. Lehmann G ME 1944 Ultraviolet irradiation and altitude fitness. Luftfahrtmedizin 9:37-43 (German).
19. Boland R 1986 Role of vitamin D in skeletal muscle function. Endocr Rev 7:434-448.
20. Buitrago C, Boland R 2010 Caveolae and caveolin-1 are implicated in 1α,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. J Steroid Biochem Mol Biol 121:169-175.
21. EndoI, Inoue D, Mitsui T, UmakiY, AkaikeM, Yoshizawa T, Kato S, Matsumoto T 2003 Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138-5144.
22. Buitrago C, González Pardo V, de Boland AR 2002 Nongenomic action of 1α,25(OH)2-vitamin D3. Activation of muscle cell PLCγ through the tyrosine kinase c-Src and PtdIns 3-kinase. Eur J Biochem 269:2506-2515.
23. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, Almandoz JP, Mullan RJ, Lane MA, Liu H, Erwin PJ, Hensrud DD, Montori VM 2011 The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997-3006.
24. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL 2011 Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22:859-871.
25. Simpson RU, Thomas GA, Arnold AJ 1985 Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260:8882-8891.
26. Costa EM, Blau HM, Feldman D 1986 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119:2214-2220.
27. Wang Y, DeLuca HF 2011 Is the vitaminDreceptor found in muscle? Endocrinology 152:354-363.
28. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835.
29. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J 2009 Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692.
30. Latham NK, Anderson CS, Reid IR 2003 Effects of vitamin Dsupplementation on strength, physical performance, and falls in older persons: a systematic review. JAmGeriatr Soc 51:1219-1226.
31. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011 Dietary reference intakes for calcium and vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Washington, DC: National Academies Press.
32. Mellanby E CM 1919 Experimental investigation on rickets. Lancet 196:407-412.
33. McCollum EV SN, Pitz W 1916 The relation of unidentified dietary factors, the fat-soluble A and water-soluble B of the diet to the growth promoting properties of milk. J Biol Chem 27:33-38.
34. McCollum EV, Simmonds N, Becker JE, Shipley PG 1922 Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 53:293-312.
35. Hess AF 1922 The prevention and cure of rickets by sunlight. Am J Public Health (NY) 12:104-107.
36. Huldschinsky K 1919 Curing rickets by artificial UV radiation. Dtsch med Wschr 45:712-713 [In German].
37. Goldblatt H, Soames KN 1923 A study of rats on a normal diet irradiated daily by the mercury vapour quartz lamp or kept in darkness. Biochem J 17:294-297.
38. Windaus A, Linsert O, Luttringhaus A, Weidlinch G 1932 Uber das krystallistierte vitamin D2. 492:226-231.
39. Holick MF, Richtand NM, McNeill SC, Holick SA, Frommer JE, Henley JW, Potts Jr JT 1979 Isolation and identification of previtamin D3 from the skin of rats exposed to ultraviolet irradiation. Biochemistry 18:1003-1008.
40. Esvelt RP, Schnoes HK, DeLuca HF 1979 Isolation and characterization of 1α-hydroxy-23-carboxytetranorvitamin D: a major metabolite of 1,25-dihydroxyvitamin D3. Biochemistry 18:3977-3983.
41. Matsuoka LY, Wortsman J, Dannenberg MJ, Hollis BW, Lu Z, Holick MF 1992 Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitaminD3. J ClinEndocrinol Metab 75:1099-1103.
42. Webb AR, Kline L, Holick MF 1988 Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373-378.
43. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF 1987 Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64:1165-1168.
44. Ponchon G, Kennan AL, DeLucaHF 1969 "Activation" of vitamin D by the liver. J Clin Invest 48:2032-2037.
45. Andersson S, Jörnvall H 1986 Sex differences in cytochrome P-450-dependent 25-hydroxylation of C27-steroids and vitamin D3 in rat liver microsomes. J Biol Chem 261:16932-16936.
46. Wikvall K 2001 Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form. Int J Mol Med 7:201-209.
47. Cheng JB, Motola DL, Mangelsdorf DJ, RussellDW2003 De-orphanization of cytochrome P450 2R1: a microsomal vitaminD25-hydroxilase. J Biol Chem 278:38084-38093.
48. Shinkyo R, Sakaki T, Kamakura M, Ohta M, Inouye K 2004 Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun 324:451-457.
49. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW 2004 Genetic evidence that the human CYP2R1 enzyme is a key vitaminD25-hydroxylase. Proc Natl Acad Sci USA 101:7711-7715.
50. Omdahl JL, Morris HA, May BK 2002 Hydroxylase enzymes of the vitaminDpathway: expression, function, and regulation. Annu Rev Nutr 22:139-166.
51. Anderson PH, May BK, Morris HA 2003 Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev 24:13-26.
52. Shinki T, Shimada H, Wakino S, Anazawa H, Hayashi M, Saruta T, DeLuca HF, Suda T 1997 Cloning and expression of rat 25-hydroxyvitamin D3-1α-hydroxylase cDNA. Proc Natl Acad Sci USA 94:12920-12925.
53. Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S 1998 Inactivating mutations in the 25-hydroxyvitamin D3 1α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338: 653-661.
54. Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-ArnaudR 2001 Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142:3135-3141.
55. Lucas PA, Woodhead JS, Brown RC 1988 VitaminD3 metabolites in chronic renal failure and after renal transplantation. Nephrol Dial Transplant 3:70-76.
56. Lucas PA, Brown RC, Woodhead JS, ColesGA1986 1,25-Dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction. Clin Nephrol 25:7-10.
57. Demetriou ET, Pietras SM, Holick MF 2010 Hypercalcemia and soft tissue calcification owing to sarcoidosis: the sunlight-cola connection. J Bone Miner Res 25:1695-1699.
58. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE 1999 An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507-515.
59. Kaseda R, Hosojima M, Sato H, Saito A 2011 Role of megalin and cubilin in the metabolism of vitamin D3. Ther Apher Dial 15(Suppl 1):14-17.
60. Brenza HL, DeLucaHF 2000 Regulation of 25-hydroxyvitamin D3 1α-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch Biochem Biophys 381:143-152.
61. Robinson CJ, Spanos E, James MF, Pike JW, HausslerMR, Makeen AM, Hillyard CJ, MacIntyre I 1982 Role of prolactin in vitamin D metabolism and calcium absorption during lactation in the rat. J Endocrinol 94:443-453.
62. Pike JW, Spanos E, Colston KW, MacIntyre I, Haussler MR 1978 Influence of estrogen on renal vitamin D hydroxylases and serum 1α,25-(OH)2D3 in chicks. Am J Physiol 235:E338-E343.
63. White JH 2012 Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Arch Biochem Biophys 523: 58-63.
64. Anderson PH, O'Loughlin PD, May BK, Morris HA 2003 Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction. J Mol Endocrinol 31:123-132.
65. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Bröking E, Fehrenbach H, Wingen AM, Güran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M 2011 Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365:410-421.
66. Brumbaugh PF, Haussler MR 1974 1α,25-Dihydroxycholecalciferol receptors in intestine. I. Association of 1α,25-dihydroxycholecalciferol with intestinal mucosa chromatin. J Biol Chem 249:1251-1257.
67. McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW 1987 Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235:1214-1217.
68. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D 2000 The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5:173-179.
69. Norman AW 2006 Vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147:5542-5548.
70. Smith CL, O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71.
71. Takeshita A, Ozawa Y, ChinWW 2000 Nuclear receptor coactivators facilitate vitamin D receptor homodimer action on direct repeat hormone response elements. Endocrinology 141:1281-1284.
72. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
73. Umesono K, Murakami KK, Thompson CC, Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255-1266.
74. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, HunzikerW1993 Two nuclear signalling pathways for vitamin D. Nature 361:657-660.
75. Dowd DR, Sutton AL, Zhang C, MacDonald P 2005 Comodulators of VDR-mediated gene expression. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. 2nd ed. San Diego: Elsevier/Academic Press; 291-304.
76. Pike JW, Meyer MB 2010 The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Endocrinol Metab Clin North Am 39:255-269.
77. Ellison TI, Eckert RL, MacDonald PN 2007 Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. J Biol Chem 282:10953-10962.
78. Prosser DE, Jones G 2004 Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29:664-673.
79. CostaEM, HirstMA, FeldmanD 1985 Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology 117:2203-2210.
80. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ 2010 Vitamin D: metabolism. Endocrinol Metab Clin North Am 39:243-253, table of contents.
81. Guyton AC, Hall JE 1996 Contraction of skeletal muscle. In: Guyton AC, Hall JE, eds. Textbook of medical physiology. Philadelphia: WB Saunders; 73-93.
82. BerchtoldMW, Brinkmeier H, MüntenerM2000 Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80:1215-1265.
83. Brooke MH, Kaiser KK 1970 Muscle fiber types: how many and what kind. Arch Neurol 23:369-379.
84. Scott W, Stevens J, Binder-Macleod SA 2001 Human skeletal muscle fiber type classifications. Phys Ther 81:1810-1816.
85. Sato Y, Iwamoto J, Kanoko T, Satoh K 2005 Low-dose vitaminDprevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 20:187-192.
86. Gordon AM, Homsher E, Regnier M 2000 Regulation of contraction in striated muscle. Physiol Rev 80:853-924.
87. Matthews VB, AströmMB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerström T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA 2009 Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52:1409-1418.
88. Pedersen BK 2009 Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 107:1006-1014.
89. Pedersen BK, Febbraio MA 2008 Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88:1379-1406.
90. Dirks-Naylor AJ, Lennon-Edwards S 2011 The effects of vitamin D on skeletal muscle function and cellular signaling. J Steroid Biochem Mol Biol 125:159-168.
91. Huxley AF, Niedergerke R 1954 Structural changes in muscle during contraction; interference microscopy of living muscle fibres. Nature 173:971-973.
92. Ojuka EO, Jones TE, Nolte LA, Chen M, Wamhoff BR, Sturek M, Holloszy JO 2002 Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca2α. AmJ Physiol Endocrinol Metab 282:E1008-E1013.
93. Ojuka EO 2004 Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 63:275-278.
94. Wright DC, Hucker KA, Holloszy JO, HanDH2004 Ca2α and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 53:330-335.
95. Witczak CA, Fujii N, Hirshman MF, Goodyear LJ 2007 Ca2α/calmodulin-dependent protein kinase kinase-α regulates skeletal muscle glucose uptake independent ofAMPactivated protein kinase and Akt activation. Diabetes 56: 1403-1409.
96. Lanner JT, Katz A, Tavi P, Sandström ME, Zhang S-J, Wretman C, James S, Fauconnier J, Lännergren J, Bruton JD, WesterbladH2006 The role of Ca2α influx for insulinmediated glucose uptake in skeletal muscle. Diabetes 55: 2077-2083.
97. Li Y, Wang P, Xu J, Gorelick F, Yamazaki H, Andrews N, DesirGV2007 Regulation of insulin secretion andGLUT4 trafficking by the calcium sensor synaptotagmin VII. Biochem Biophys Res Commun 362:658-664.
98. Lanner JT, Bruton JD, Katz A, Westerblad H 2008 Ca2α and insulin-mediated glucose uptake. Curr Opin Pharmacol 8:339-345.
99. Gundersen K 2011 Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol Rev Camb Philos Soc 86:564-600.
100. Tavi P, WesterbladH2011 The role of in vivo Ca2αsignals acting on Ca2α-calmodulin-dependent proteins for skeletal muscle plasticity. J Physiol 589:5021-5031.
101. Michel RN, Chin ER, Chakkalakal JV, Eibl JK, Jasmin BJ 2007 Ca2α/calmodulin-based signalling in the regulation of the muscle fibre phenotype and its therapeutic potential via modulation of utrophin A and myostatin expression. Appl Physiol Nutr Metab 32:921-929.
102. Ryder JW, Gilbert M, Zierath JR 2001 Skeletal muscle and insulin sensitivity: pathophysiological alterations. Front Biosci 6:D154-D163.
103. TaniguchiCM, Emanuelli B, KahnCR2006 Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96.
104. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142.
105. HuangS, CzechMP2007 TheGLUT4glucose transporter. Cell Metab 5:237-252.
106. Munshi HG, Burks DJ, Joyal JL, White MF, Sacks DB 1996 Ca2α regulates calmodulin binding to IQ motifs in IRS-1. Biochemistry 35:15883-15889.
107. Haussler MR, Norman AW 1969 Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 62: 155-162.
108. Walters MR, Hunziker W, Norman AW 1980 Cytosol preparations are inadequate for quantitating unoccupied receptors for 1,25-dihydroxyvitamin D3. J Recept Res 1:313-327.
109. Nemere I, Schwartz Z, Pedrozo H, Sylvia VL, Dean DD, Boyan BD 1998 Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res 13:1353-1359.
110. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW 2004 The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18:2660-2671.
111. Bula CM, Huhtakangas J, Olivera C, Bishop JE, Norman AW, Henry HL 2005 Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 146:5581-5586.
112. Bauman VK, Valinietse MY, BabarykinDA 1984 Vitamin D3 and 1,25-dihydroxyvitamin D3 stimulate the skeletal muscle-calcium mobilization in rachitic chicks. Arch Biochem Biophys 231:211-216.
113. Santillán G, Katz S, Vazquez G, Boland RL 2004 TRPC3-like protein and vitamin D receptor mediate 1α,25(OH)2D3-induced SOC influx in muscle cells. Int J Biochem Cell Biol 36:1910-1918.
114. Santillán G, Baldi C, Katz S, Vazquez G, Boland R 2004 Evidence that TRPC3 is a molecular component of the 1α,25(OH)2D3-activated capacitative calcium entry (CCE) in muscle and osteoblast cells. J Steroid Biochem Mol Biol 89-90:291-295.
115. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stähelin HB, DickW2001 In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33:19-24.
116. Wang Y, Becklund BR, DeLuca HF 2010 Identification of a highly specific and versatile vitaminDreceptor antibody. Arch Biochem Biophys 494:166-177.
117. Capiati D, Benassati S, Boland RL 2002 1,25(OH)2-Vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 86:128-135.
118. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN 2011 1,25(OH)2Vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152: 2976-2986.
119. Buitrago C, Vazquez G, De Boland AR, Boland RL 2000 Activation of Src kinase in skeletal muscle cells by 1,25-(OH2)-vitamin D3 correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. J Cell Biochem 79:274-281.
120. Buitrago C, Boland R, de Boland AR 2001 The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells. Biochim Biophys Acta 1541:179-187.
121. Grucza RA, Bradshaw JM, Fütterer K, Waksman G 1999 SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationships. Med Res Rev 19:273-293.
122. Mizwicki MT, Keidel D, Bula CM, Bishop JE, Zanello LP, Wurtz JM, Moras D, Norman AW 2004 Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH)2-vitaminD3 signaling. Proc Natl Acad Sci USA 101:12876-12881.
123. Menegaz D, Mizwicki MT, Barrientos-Duran A, Chen N, Henry HL, Norman AW 2011 Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP). Mol Endocrinol 25:1289-1300.
124. Baran DT, Quail JM, Ray R, Leszyk J, Honeyman T 2000 Annexin II is the membrane receptor that mediates the rapid actions of 1α,25-dihydroxyvitamin D3. J Cell Biochem 78:34-46.
125. Mizwicki MT, Bishop JE, Olivera CJ, Huhtakangas J, Norman AW 2004 Evidence that annexin II is not a putative membrane receptor for 1α,25(OH)2-vitaminD3. J Cell Biochem 91:852-863.
126. Khanal R, Nemere I 2007 Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr 17:31-47.
127. Vazquez G, Boland R, de Boland AR 1995 Modulation by 1,25(OH)2-vitamin D3 of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. Biochim Biophys Acta 1269:91-97.
128. Capiati DA, Vazquez G, Boland RL 2001 Protein kinase Cα modulates the Ca2α influx phase of the Ca2α response to 1α,25-dihydroxy-vitamin-D3 in skeletal muscle cells. Horm Metab Res 33:201-206.
129. Boland RL 2011 VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 347: 11-16.
130. Morelli S, de Boland AR, Boland RL 1993 Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1,25-dihydroxyvitamin D3. Biochem J 289 (Pt 3):675-679.
131. Vazquez G, de Boland AR, Boland RL 2000 Involvement of calmodulin in 1α,25-dihydroxyvitamin D3 stimulation of store-operatedCa2αinflux in skeletal muscle cells. J Biol Chem 275:16134-16138.
132. Capiati DA, Vazquez G, Tellez Iñón MT, Boland RL 2000 Role of protein kinase C in 1,25(OH)2-vitamin D3 modulation of intracellular calcium during development of skeletal muscle cells in culture. J Cell Biochem 77:200-212.
133. Vazquez G, de Boland AR 1996 Involvement of protein kinase C in the modulation of 1α,25-dihydroxy-vitamin D3-induced 45Ca2α uptake in rat and chick cultured myoblasts. Biochim Biophys Acta 1310:157-162.
134. Fernandez LM, Massheimer V, de Boland AR 1990 Cyclic AMP-dependent membrane protein phosphorylation and calmodulin binding are involved in the rapid stimulation of muscle calcium uptake by 1,25-dihydroxyvitaminD3. Calcif Tissue Int 47:314-319.
135. Vazquez G, de Boland AR, BolandRL1997 1a,25-(OH)2-Vitamin D3 stimulates the adenylyl cyclase pathway in muscle cells by a GTP-dependent mechanism which presumably involves phosphorylation of Gai. Biochem Biophys Res Commun 234:125-128.
136. Curry OB, Basten JF, Francis MJ, Smith R 1974 Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits. Nature 249:83-84.
137. Birge SJ, Haddad JG 1975 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56:1100-1107.
138. Bellido T, Boland RL 1985 In vitro muscle phosphate uptake. Characteristics and action of vitaminD3 metabolites. In: Norman AW, Schaefer H, Grigoleit HG, eds. Vitamin D: a chemical, biochemical, and clinical update. Berlin: Walter de Gruyter; pp. 590-591.
139. De Boland AR, Gallego S, Boland R 1983 Effects of vitamin D-3 on phosphate and calcium transport across and composition of skeletal muscle plasma cell membranes. Biochim Biophys Acta 733:264-273.
140. Boland R, Matthews C, de Boland AR, Ritz E, Hasselbach W 1983 Reversal of decreased phosphorylation of sarcoplasmic reticulum calcium transport ATPase by 1,25-dihydroxycholecalciferol in experimental uremia. Calcif Tissue Int 35:195-201.
141. de Boland AR, Albornoz LE, Boland R 1983 The effect of cholecalciferol in vivo on proteins and lipids of skeletal muscle from rachitic chicks. Calcif Tissue Int 35:798-805.
142. Morelli S, Buitrago C, Boland R, de Boland AR 2001 The stimulation of MAP kinase by 1,25(OH)2-vitamin D3 in skeletal muscle cells is mediated by protein kinase C and calcium. Mol Cell Endocrinol 173:41-52.
143. Buitrago CG, Pardo VG, de Boland AR, Boland R 2003 Activation of RAF-1 through Ras and protein kinase Cα mediates 1α,25(OH)2-vitamin D3 regulation of the mitogen-activated protein kinase pathway in muscle cells. J Biol Chem 278:2199-2205.
144. Ronda AC, Buitrago C, Colicheo A, de Boland AR, Roldán E, Boland R 2007 Activation of MAPKs by 1α,25(OH)2-vitamin D3 and 17β-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors. J Steroid Biochem Mol Biol 103:462-466.
145. Boland R, De Boland AR, Buitrago C, Morelli S, SantillánG, Vazquez G, Capiati D, Baldi C 2002 Non-genomic stimulation of tyrosine phosphorylation cascades by 1,25(OH)2D3 by VDR-dependent and-independent mechanisms in muscle cells. Steroids 67:477-482.
146. Buitrago CG, Ronda AC, de Boland AR, Boland R 2006 MAP kinases p38 and JNK are activated by the steroid hormone 1α,25(OH)2-vitamin D3 in the C2C12 muscle cell line. J Cell Biochem 97:698-708.
147. An SS, Fabry B, Mellema M, Bursac P, Gerthoffer WT, Kayyali US, Gaestel M, Shore SA, Fredberg JJ 2004 Role of heat shock protein 27 in cytoskeletal remodeling of the airway smooth muscle cell. J Appl Physiol 96:1701-1713.
148. Buitrago CG, Arango NS, Boland RL 2012 1α,25(OH)2 D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. J Cell Biochem 113:1170-1181.
149. Alami-Durante H, Cluzeaud M, Bazin D, Mazurais D, Zambonino-Infante JL 2011 Dietary cholecalciferol regulates the recruitment and growth of skeletal muscle fibers and the expressions of myogenic regulatory factors and the myosin heavy chain in European sea bass larvae. J Nutr 141:2146-2151.
150. Braun T, GautelM 2011 Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 12:349-361.
151. Pointon JJ, Francis MJ, Smith R 1979 Effect of vitamin D deficiency on sarcoplasmic reticulum function and troponin C concentration of rabbit skeletal muscle. Clin Sci (Lond) 57:257-263.
152. Ströder J, Arensmeyer E 1965 [Actomyosin content of the skeletal muscles in experimental rickets]. Klin Wochenschr 43:1201-1202 (German).
153. Min Y, Lowy C, Islam S, Khan FS, Swaminathan R 2011 Relationship between red cell membrane fatty acids and adipokines in individuals with varying insulin sensitivity. Eur J Clin Nutr 65:690-695.
154. de Boland AR, Boland R 1985 Suppression of 1,25-dihydroxy-vitaminD3-dependent calcium transport by protein synthesis inhibitors and changes in phospholipids in skeletal muscle. Biochim Biophys Acta 845:237-241.
155. Breen ME, Laing EM, Hall DB, Hausman DB, Taylor RG, Isales CM, Ding KH, Pollock NK, Hamrick MW, Baile CA, Lewis RD 2011 25-Hydroxyvitamin D, insulin-like growth factor-I, and bone mineral accrual during growth. J Clin Endocrinol Metab 96:E89-E98.
156. Willis CM, Laing EM, Hall DB, Hausman DB, Lewis RD 2007Aprospective analysis of plasma 25-hydroxyvitamin Dconcentrations in white and black prepubertal females in the southeastern United States. Am J Clin Nutr 85:124-130.
157. Rauch F, Bailey DA, Baxter-Jones A, Mirwald R, Faulkner R2004 The 'muscle-bone unit' during the pubertal growth spurt. Bone 34:771-775.
158. Prié D, Friedlander G 2010 Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Clin J Am Soc Nephrol 5:1717-1722.
159. Aono Y, Hasegawa H, Yamazaki Y, Shimada T, Fujita T, Yamashita T, Fukumoto S 2011 Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice. J Bone Miner Res 26:803-810.
160. Leal MA, Aller P, Mas A, Calle C 1995 The effect of 1,25-dihydroxyvitamin D3 on insulin binding, insulin receptor mRNA levels, and isotype RNA pattern in U-937 human promonocytic cells. Exp Cell Res 217:189-194.
161. Maestro B, Campión J, Dávila N, Calle C 2000 Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47:383-391.
162. Maestro B, Dávila N, Carranza MC, Calle C 2003 Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid BiochemMolBiol 84:223-230.
163. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, ZhangX 2008 1,25-Dihydroxyvitamin D improved the free fattyacid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 24:459-464.
164. de Boland AR, Boland RL 1993 1,25-Dihydroxyvitamin D-3 induces arachidonate mobilization in embryonic chick myoblasts. Biochim Biophys Acta 1179:98-104.
165. Boucher BJ 2009 Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle. Diabetologia 52:2240; author reply 2241-2243.
166. Oh YS, Khil LY, Cho KA, Ryu SJ, Ha MK, Cheon GJ, Lee TS, Yoon JW, Jun HS, Park SC 2008 A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia 51:1025-1034.
167. Kim CA, Delépine M, Boutet E, El Mourabit H, Le Lay S, Meier M, Nemani M, Bridel E, Leite CC, Bertola DR, Semple RK, O'Rahilly S, Dugail I, Capeau J, Lathrop M, Magré J 2008 Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93:1129-1134.
168. Kanakamani J, Tomar N, Kaushal E, Tandon N, Goswami R 2010 Presence of a deletion mutation (c. 716delA) in the ligand binding domain of the vitamin D receptor in an Indian patient with vitamin D-dependent rickets type II. Calcif Tissue Int 86:33-41.
169. Bergman R, Schein-Goldshmid R, Hochberg Z, Ben-Izhak O, Sprecher E 2005 The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study. Arch Dermatol 141:343-351.
170. Seoane S, Alonso M, Segura C, Pérez-Fernández R 2002 Localization of a negative vitamin D response sequence in the human growth hormone gene. Biochem Biophys Res Commun 292:250-255.
171. Sakoda K, Fujiwara M, Arai S, Suzuki A, Nishikawa J, Imagawa M, Nishihara T 1996 Isolation of a genomic DNA fragment having negative vitamin D response element. Biochem Biophys Res Commun 219:31-35.
172. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P 2004 Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 15:1271-1274.
173. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P 2004 Impaired motor performance in mice lacking neurosteroid vitaminD receptors. Brain Res Bull 64:25-29.
174. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A 2006 Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res Bull 69: 74-78.
175. Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, Syvälä H, Lou YR, Kalueff AV, PyykköI, Tuohimaa P 2009 Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 114:161-166.
176. Schubert L, DeLuca HF 2010 Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500:157-161.
177. Rodman JS, Baker T 1978 Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int 13: 189-193.
178. Pleasure D, Wyszynski B, Sumner A, Schotland D, Feldman B, Nugent N, Hitz K, Goodman DB 1979 Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks. J Clin Invest 64:1157-1167.
179. Tague SE, Clarke GL, Winter MK, McCarson KE, Wright DE, Smith PG 2011 Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. J Neurosci 31:13728-13738.
180. Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, Overbergh L, Bouillon R, Mathieu C 2004 VitaminDdeficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451-462.
181. Kawashima H, Castro A 1981 Effect of 1α-hydroxyvitamin D3 on the glucose and calcium metabolism in genetic obese mice. Res Commun Chem Pathol Pharmacol 33: 155-161.
182. Chang-Quan H, Bi-Rong D, Zhen-Chan HPL 2008 Insufficient renal 1-alpha hydroxylase and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus. J Bone Miner Metab 26:561-568.
183. Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG 2011 Cardiomyocytespecific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124:1838-1847.
184. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR 2001 Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145-159.
185. Roth SM, ZmudaJM, Cauley JA, Shea PR, FerrellRE2004 Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 59:10-15.
186. Hopkinson NS, Li KW, Kehoe A, Humphries SE, Roughton M, Moxham J, Montgomery H, Polkey MI 2008 Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 87:385-390.
187. Windelinckx A, De Mars G, Beunen G, Aerssens J, Delecluse C, Lefevre J, ThomisMA2007 Polymorphisms in the vitamin D receptor gene are associated with muscle strength in men and women. Osteoporos Int 18:1235-1242.
188. Ceglia L 2008 Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 29:407-414.
189. Geusens P, Vandevyver C, Vanhoof J, Cassiman JJ, Boonen S, Raus J 1997 Quadriceps and grip strength are related to vitaminDreceptor genotype in elderly nonobese women. J Bone Miner Res 12:2082-2088.
190. Grundberg E, Brändström H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A 2004 Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol 150:323-328.
191. Wang P, Ma LH, Wang HY, Zhang W, Tian Q, Cao DN, Zheng GX, Sun YL 2006 Association between polymorphisms of vitamin D receptor gene ApaI, BsmI and TaqI and muscular strength in young Chinese women. Int J Sports Med 27:182-186.
192. Bahat G, Saka B, Erten N, Ozbek U, Coskunpinar E, Yildiz S, Sahinkaya T, Karan MA 2010 BsmI polymorphism in the vitamin D receptor gene is associated with leg extensor muscle strength in elderly men. Aging Clin Exp Res 22: 198-205.
193. Onder G, Capoluongo E, Danese P, Settanni S, Russo A, Concolino P, Bernabei R, Landi F 2008 VitaminDreceptor polymorphisms and falls among older adults living in the community: results from the ilSIRENTE study. J Bone Miner Res 23:1031-1036.
194. Barr R, Macdonald H, Stewart A, McGuigan F, Rogers A, Eastell R, Felsenberg D, Glüer C, Roux C, Reid DM 2010 Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int 21:457-466.
195. Clifton-Bligh RJ, Nguyen TV, Au A, Bullock M, Cameron I, Cumming R, Chen JS, March LM, Seibel MJ, Sambrook PN 2011 Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderly. Calcif Tissue Int 88:109-116.
196. Whistler D 1645 De morbo puerili Anglorum quem patrio idiomate indigenae vocant the rickets. University of Leidon doctoral dissertation. Oxford: Alexander Cooke.
197. Glisson F 1651 A treatise of the rickets: being a disease common to children. Culpeper N, ed. London: P Cole.
198. Chalmers J, Conacher WD, Gardner DL, Scott PJ 1967 Osteomalacia: a common disease in elderly women. J Bone Joint Surg Br 49:403-423.
199. Chalmers J, Conacher W, Gardner D, Scott P 1967 Osteomalacia: a common disease in elderly women. J Bone Joint Surg Br 49:403-423.
200. Russell JA 1994 Osteomalacic myopathy. Muscle Nerve 17:578-580.
201. Irani PF 1976 Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 39:686-693.
202. Schott GD, Wills MR 1976 Muscle weakness in osteomalacia. Lancet 1:626-629.
203. FloydM, Ayyar DR, BarwickDD, Hudgson P, Weightman D 1974 Myopathy in chronic renal failure. Q J Med 43: 509-524.
204. Amstrup AK, Rejnmark L, Vestergaard P, Sikjaer T, Rolighed L, Heickendorff L, Mosekilde L 2011 Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls: a cross-sectional study. Clin Endocrinol (Oxf) 74:130-136.
205. Al-SaidYA, Al-Rached HS, Al-QahtaniHA, JanMM 2009 Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci 36:336-339.
206. Hamilton B 2010 Vitamin D and human skeletal muscle. Scand J Med Sci Sports 20:182-190.
207. Ziambaras K, Dagogo-Jack S 1997 Reversible muscle weakness in patients with vitamin D deficiency. West J Med 167:435-439.
208. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF 2000 Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419-424.
209. Prabhala A, Garg R, Dandona P 2000 Severe myopathy associated with vitaminDdeficiency in westernNewYork. Arch Intern Med 160:1199-1203.
210. Whitaker CH, Malchoff CD, Felice KJ 2000 Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism. Amyotroph Lateral Scler Other Motor Neuron Disord 1:283-286.
211. Plotnikoff GA, Quigley JM 2003 Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78:1463-1470.
212. Macfarlane G, Palmer B, Roy D, Afzal C, Silman A, O'NeillT2005Anexcess of widespread pain among South Asians: are low levels of vitaminDimplicated. AnnRheum Dis 64:1217-1219.
213. Mouyis M, Ostor AJ, Crisp AJ, Ginawi A, Halsall DJ, Shenker N, Poole KE 2008 Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford) 47:1348-1351.
214. Warner AE, Arnspiger SA 2008 Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14:12-16.
215. Block SR 2004 VitaminDdeficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc 79:1585-1586; author reply 1586-1587.
216. Myers KJ 2004 Vitamin D deficiency and chronic pain: cause and effect or epiphenomenon. Mayo Clin Proc 79: 695; author reply 695-696.
217. McBeth J, Pye SR, O'Neill TW, Macfarlane GJ, Tajar A, Bartfai G, Boonen S, Bouillon R, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Wu FC 2010 Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis 69: 1448-1452.
218. Ford JA, Colhoun EM, McIntosh WB, Dunnigan MG 1972 Rickets and osteomalacia in the Glasgow Pakistani community, 1961-71. Br Med J 2:677-680.
219. Preece MA, McIntosh WB, Tomlinson S, Ford JA, Dunnigan MG, O'Riordan JL 1973 Vitamin-D deficiency among Asian immigrants to Britain. Lancet 1:907-910.
220. de Torrenté de la Jara G, Pécoud A, Favrat B 2006 Female asylum seekers with musculoskeletal pain: the importance of diagnosis and treatment of hypovitaminosis D. BMC Fam Pract 7:4.
221. Badsha H, Daher M, Ooi Kong K 2009 Myalgias or nonspecific muscle pain in Arab or Indo-Pakistani patientsmay indicate vitamin D deficiency. Clin Rheumatol 28:971-973.
222. Nellen JF, Smulders YM, Jos Frissen PH, Slaats EH, Silberbusch J 1996 HypovitaminosisDin immigrant women: slow to be diagnosed. BMJ 312:570-572.
223. Benson J, Wilson A, Stocks N, Moulding N 2006 Muscle pain as an indicator of vitamin D deficiency in an urban Australian Aboriginal population. Med J Aust 185:76-77.
224. DupontWD, PlummerWD 1997 PS power and sample size program available for free on the Internet. Control Clin Trials 18:274.
225. Reginato AJ, Coquia JA 2003 Musculoskeletal manifestations of osteomalacia and rickets. Best Pract Res Clin Rheumatol 17:1063-1080.
226. Gloth 3rd FM, Lindsay JM, Zelesnick LB, Greenough 3rd WB 1991 Can vitamin D deficiency produce an unusual pain syndrome. Arch Intern Med 151:1662-1664.
227. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hyppönen E 2009 VitaminDand chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis 68: 817-822.
228. de Rezende Pena C, Grillo LP, das Chagas MedeirosMM 2010 Evaluation of 25-hydroxyvitamin D serum levels in patients with fibromyalgia. J Clin Rheumatol 16:365-369.
229. Al-Allaf AW, Mole PA, Paterson CR, Pullar T 2003 Bone health in patients with fibromyalgia. Rheumatology (Oxford) 42:1202-1206.
230. Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, Mast DJ, Sanford PB, Sjoberg RJ 2009 Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 15:203-212.
231. Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa SE, O'Dea AP, Klemp JR, Fabian CJ 2010 Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119: 111-118.
232. Rastelli AL, Taylor ME, Gao F, Armamento-Villareal R, Jamalabadi-Majidi S, Napoli N, EllisMJ2011 VitaminD and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat 129: 107-116.
233. Gupta A, Thompson PD 2011 The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 215: 23-29.
234. Lee JH, O'Keefe JH, Bell D, Hensrud DD, HolickMF2008 Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52:1949-1956.
235. GoldsteinMR2007 Myopathy, statins, and vitamin D deficiency. Am J Cardiol 100:1328.
236. Bell DS 2010 Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 103:690-692.
237. Backes JM, Barnes BJ, Ruisinger JF, Moriarty PM 2011 A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias. Atherosclerosis 218:247-249.
238. Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, Uppal M, Khanal S 2009 Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 153:11-16.
239. Lee P, Greenfield JR, Campbell LV 2009 Vitamin D insufficiency: a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf) 71:154-155.
240. Glueck CJ, Budhani SB, Masineni SS, Abuchaibe C, Khan N, Wang P, Goldenberg N 2011 Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance. Curr Med Res Opin 27:1683-1690.
241. Linde R, Peng L, Desai M, Feldman D 2010 The role of vitamin D and SLCO1B1*5 gene polymorphism in statinassociated myalgias. Dermatoendocrinol 2:77-84.
242. Kurnik D, Hochman I, Vesterman-Landes J, Kenig T, Katzir I, Lomnicky Y, Halkin H, LoebsteinR2011 Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf) 77:36-41.
243. Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L 2010 Simvastatin does not affect vitaminDstatus, but low vitamin D levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol 2010: 957174.
244. Dobs AS, Levine MA, Margolis S 1991 Effects of pravastatin, a newHMG-CoAreductase inhibitor, on vitaminD synthesis in man. Metabolism 40:524-528.
245. Gupta RP, Hollis BW, Patel SB, Patrick KS, BellNH 2004 CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 19:680-688.
246. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH 2003 Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003:CD000340.
247. Vellas BJ, Wayne SJ, Romero LJ, Baumgartner RN, Garry PJ 1997 Fear of falling and restriction of mobility in elderly fallers. Age Ageing 26:189-193.
248. Marzetti E, Leeuwenburgh C 2006 Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol 41: 1234-1238.
249. Campbell AJ, Spears GF, Borrie MJ, Fitzgerald JL 1988 Falls, elderly women and the cold. Gerontology 34:205-208.
250. Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, Thomasx J, Hopper JL, Wark JD 2003 Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 51:1533-1538.
251. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P 2006 Vitamin D status in relation to oneyear risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980-2985.
252. Stein MS, Wark JD, Scherer SC, Walton SL, Chick P, Di Carlantonio M, Zajac JD, Flicker L 1999 Falls relate to vitaminDand parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 47:1195-1201.
253. Sambrook PN, Cameron ID, Chen JS, Cumming RG, Durvasula S, Herrmann M, Kok C, Lord SR, Macara M, March LM, Mason RS, Seibel MJ, Wilson N, Simpson JM 2012 Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int 23:615-624.
254. Larsen ER, Mosekilde L, FoldspangA2005 VitaminDand calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic populationbased 3-year intervention study. Aging Clin Exp Res 17: 125-132.
255. Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Wark JD 2005 Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 53:1881-1888.
256. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B 2006 Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166:424-430.
257. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676.
258. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H 2009 Effects of a long-term vitamin Dand calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20:315-322.
259. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, ConzelmannM2003 Effects of vitaminDand calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-351.
260. Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K 2008 Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 168: 103-108.
261. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C 2000 Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113-1118.
262. Pfeifer M, Begerow B, Minne HW, Schlotthauer T, Pospeschill M, Scholz M, Lazarescu AD, Pollähne W 2001 Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109:87-92.
263. Graafmans WC, Ooms ME, Hofstee HM, Bezemer PD, Bouter LM, Lips P 1996 Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 143:1129-1136.
264. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP 2007 A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 55:234-239.
265. GrantAM, Avenell A, CampbellMK, McDonaldAM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA 2005 Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621-1628.
266. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ 2005 Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330:1003.
267. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC 2010 Annual highdose oral vitaminDand falls and fractures in older women: a randomized controlled trial. JAMA 303:1815-1822.
268. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C 2007 Effect of annual intramuscular vitamin D on fracture risk in elderly men and women: a populationbased, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 46:1852-1857.
269. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB 2004 Effect of Vitamin D on falls: a meta-analysis. JAMA 291: 1999-2006.
270. Jackson C, Gaugris S, Sen SS, Hosking D 2007 The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM 100:185-192.
271. Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, CrewsDC2010 VitaminDtreatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc 58:1299-1310.
272. Richy F, Dukas L, Schacht E 2008 Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif Tissue Int 82: 102-107.
273. Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM 2008 The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 56:454-461.
274. Mastaglia SR, Seijo M, Muzio D, Somoza J, Nuñez M, Oliveri B 2011 Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging 15:349-354.
275. Houston DK, Cesari M, Ferrucci L, Cherubini A, Maggio D, Bartali B, Johnson MA, Schwartz GG, Kritchevsky SB 2007 Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 62:440-446.
276. Annweiler C, Schott AM, Berrut G, Fantino B, BeauchetO 2009 Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging 13:893-898.
277. Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, Tyndall A, Theiler R 1999 Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80:54-58.
278. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B 2004 Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60 y. Am J Clin Nutr 80:752-758.
279. Wicherts IS, van SchoorNM, Boeke AJ, VisserM, Deeg DJ, Smit J, Knol DL, Lips P 2007 Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92:2058-2065.
280. Visser M, Deeg DJ, Lips P 2003 Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88: 5766-5772.
281. Dam TT, von Mühlen D, Barrett-Connor EL 2009 Sexspecific association of serum vitaminDlevels with physical function in older adults. Osteoporos Int 20:751-760.
282. Chan R, Chan D, Woo J, Ohlsson C, Mellström D, Kwok T, Leung PC 2012 Not all elderly people benefit from vitamin D supplementation with respect to physical function: results from the osteoporotic fractures in men study, Hong Kong. J Am Geriatr Soc 60:290-295.
283. Bunout D, Barrera G, Leiva L, Gattas V, de la Maza MP, Avendaño M, Hirsch S 2006 Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitaminDdeficient elderly subjects. Exp Gerontol 41:746-752.
284. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, Allain TJ 2004 Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33:589-595.
285. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M 2009 Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab 54:291-300.
286. Zhu K, Austin N, Devine A, Bruce D, Prince RL 2010 A randomized controlled trial of the effects of vitamin D on muscle strength and mobility in older women with vitamin D insufficiency. J Am Geriatr Soc 58:2063-2068.
287. Ward KA, Das G, Roberts SA, Berry JL, Adams JE, Rawer R, Mughal MZ 2010 A randomized, controlled trial of vitamin D supplementation upon musculoskeletal health in postmenarchal females. J Clin Endocrinol Metab 95: 4643-4651.
288. Songpatanasilp T, Chailurkit LO, Nichachotsalid A, Chantarasorn M 2009 Combination of alfacalcidol with calcium can improve quadriceps muscle strength in elderly ambulatory Thai women who have hypovitaminosis D: a randomized controlled trial. J Med Assoc Thai 92(Suppl 5):S30-S41.
289. Janssen HC, Samson MM, Verhaar HJ 2010 Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitaminD and calcium supplementation. Aging Clin Exp Res 22: 78-84.
290. Glendenning P, Zhu K, Inderjeeth C, Howat P, Lewis JR, PrinceRL28 September 2011 Effects of three monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility and muscle strength in older postmenopausal women: a randomised controlled trial. J Bone Miner Res 10.1002/jbmr.524.
291. Latham NK, Anderson CS, Lee A, Bennett DA, Moseley A, Cameron ID 2003 A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 51:291-299.
292. Corless D, Dawson E, Fraser F, Ellis M, Evans SJ, Perry JD, Reisner C, Silver CP, Beer M, Boucher BJ, et al 1985 Do vitaminDsupplements improve the physical capabilities of elderly hospital patients. Age Ageing 14:76-84.
293. Kukuljan S, Nowson CA, Sanders K, Daly RM 2009 Effects of resistance exercise and fortified milk on skeletal muscle mass, muscle size, and functional performance in middle-aged and older men: an 18-mo randomized controlled trial. J Appl Physiol 107:1864-1873.
294. Grady D, Halloran B, Cummings S, Leveille S, Wells L, Black D, Byl N 1991 1,25-DihydroxyvitaminD3 and muscle strength in the elderly: a randomized controlled trial. J Clin Endocrinol Metab 73:1111-1117.
295. El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, Khalife H, Choucair M, Arabi A, Vieth R 2006 Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab 91:405-412.
296. Rejnmark L 2011 Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis 2:25-37.
297. Muir SW, Montero-Odasso M 2011 Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 59:2291-2300.
298. Lazaro RP, Kirshner HS 1980 Proximal muscle weakness in uremia. Case reports and review of the literature. Arch Neurol 37:555-558.
299. Dastur DK, Gagrat BM, Wadia NH, Desai M, Bharucha EP 1975 Nature of muscular change in osteomalacia: lightand electron-microscope observations. J Pathol 117:211-228.
300. Yoshikawa S, Nakamura T, Tanabe H, Imamura T 1979 Osteomalacic myopathy. Endocrinol Jpn 26:65-72.
301. Sorensen OH, Lund B, Saltin B, Andersen RB, Hjorth L, Melsen F, Mosekilde L 1979 Myopathy in bone loss of ageing: improvement by treatment with 1α-hydroxycholecalciferol and calcium. Clin Sci (Lond) 56:157-161.
302. Young A, Brenton DP, EdwardsR 1978 Analysis of muscle weakness in osteomalacia. Clin Sci Mol Med 54:31.
303. Gilsanz V, Kremer A, Mo AO, Wren TA, Kremer R 2010 Vitamin D status and its relation to muscle mass and muscle fat in young women. J Clin Endocrinol Metab 95:1595-1601.
304. Oh JH, Kim SH, Kim JH, Shin YH, Yoon JP, Oh CH 2009 The level of vitamin D in the serum correlates with fatty degeneration of the muscles of the rotator cuff. J Bone Joint Surg Br 91:1587-1593.
305. Tagliafico AS, Ameri P, Bovio M, Puntoni M, Capaccio E, Murialdo G, Martinoli C 2010 Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study. AJR Am J Roentgenol 194:728-734.
306. Marantes I, Achenbach SJ, Atkinson EJ, Khosla S, Melton 3rd LJ, Amin S 2011 Is vitamin D a determinant of muscle mass and strength. J Bone Miner Res 26:2860-2871.
307. Gordon PL, Doyle JW, Johansen KL 2012 Association of 1,25-dihydroxyvitamin D levels with physical performance and thigh muscle cross-sectional area in chronic kidney disease stage 3 and 4. J Ren Nutr 22:423-433.
308. Ducher G, Kukuljan S, Hill B, Garnham AP, Nowson CA, Kimlin MG, Cook J 2011 Vitamin D status and musculoskeletal health in adolescent male ballet dancers a pilot study. J Dance Med Sci 15:99-107.
309. Nigro J, Osman N, Dart AM, Little PJ 2006 Insulin resistance and atherosclerosis. Endocr Rev 27:242-259.
310. Pinelli NR, Jaber LA, Brown MB, Herman WH 2010 Serum 25-hydroxy vitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 33:1373-1375.
311. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF 2009 Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139:329-334.
312. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ 2010 Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33:1379-1381.
313. Ford ES, Zhao G, Tsai J, Li C 2011 Associations between concentrations of vitaminDand concentrations of insulin, glucose, and HbA1c among adolescents in the United States. Diabetes Care 34:646-648.
314. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A 2010 25-HydroxyvitaminDconcentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906-1910.
315. Del Gobbo LC, Song Y, Dannenbaum DA, Dewailly E, Egeland GM 2011 Serum 25-hydroxyvitamin D is not associated with insulin resistance or β-cell function in Canadian Cree. J Nutr 141:290-295.
316. Gannagé-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G 2009 Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 160:965-971.
317. Chiu KC, Chu A, Go VL, Saad MF 2004 Hypovitaminosis D is associated with insulin resistance and β-cell dysfunction. Am J Clin Nutr 79:820-825.
318. Scragg R, Sowers M, Bell C 2004 Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813-2818.
319. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ 2010 Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59:242-248.
320. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD 2008 Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 7:4.
321. Manco M, Calvani M, Nanni G, Greco AV, Iaconelli A, Gasbarrini G, Castagneto M, Mingrone G 2005 Low 25-hydroxyvitaminDdoes not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 13:1692-1700.
322. Taylor WH, Khaleeli AA 2001 Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17:175-180.
323. Kamycheva E, Jorde R, Figenschau Y, Haug E 2007 Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitaminDlevel on insulin sensitivity. J Endocrinol Invest 30:126-132.
324. Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ 2011 Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 96:168-175.
325. Isaia G, Giorgino R, Adami S 2001 High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 24:1496.
326. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A 2010 The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract 64:351-355.
327. Brock KE, Huang WY, Fraser DR, Ke L, Tseng M, Mason RS, Stolzenberg-Solomon RZ, Freedman DM, Ahn J, Peters U, McCarty C, Hollis BW, Ziegler RG, Purdue MP, Graubard BI 2011 Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a crosssectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr 106:339-344.
328. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E 1995 Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27:181-188.
329. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B 2009 The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 36:205-210.
330. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN 1997 Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 46:1171-1177.
331. Al-Daghri NM, Al-Attas OS, Al-Okail MS, Alkharfy KM, Al-Yousef MA, Nadhrah HM, Sabico SB, Chrousos GP 2010 Severe hypovitaminosis D is widespread and more common in non-diabetics than diabetics in Saudi adults. Saudi Med J 31:775-780.
332. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ 2008 Baseline serum 25-hydroxy vitaminDis predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57:2619-2625.
333. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Grantham N, Ebeling PR, DalyRM 2011 Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 34: 1133-1138.
334. Pittas AG, Dawson-Hughes B, Li T, VanDamRM, Willett WC, Manson JE, Hu FB 2006 Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650-656.
335. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM 2005 Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:2926-2932.
336. Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan D, Hu FB, Dawson-Hughes B; Diabetes Prevention Program Research Group 2012 Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 35:565-573.
337. Robinson JG, Manson JE, Larson J, Liu S, Song Y, Howard BV, Phillips L, Shikany JM, Allison M, Curb JD, Johnson KC, Watts N 2011 Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 34:628-634.
338. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R 2010 Baseline serum 25-hydroxyvitaminDconcentrations in the Tromso Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 27:1107-1115.
339. Mattila C, Knekt P, MännistöS, Rissanen H, Laaksonen MA, Montonen J, Reunanen A 2007 Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30:2569-2570.
340. Nilas L, ChristiansenC 1984 Treatment with vitaminDor its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes 8:407-411.
341. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E 1997 No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 27:629-633.
342. Mitri J, Dawson-Hughes B, Hu FB, PittasAG2011 Effects of vitamin D and calcium supplementation on pancreatic β-cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94:486-494.
343. Nagpal J, Pande JN, Bhartia A 2009 A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26:19-27.
344. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B 2007 The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care 30:980-986.
345. von Hurst PR, Stonehouse W, Coad J 2010 Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitaminDdeficient: a randomised, placebo-controlled trial. Br J Nutr 103:549-555.
346. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A, Heravifard S, Tayebinejad N, Salekzamani S, Zahedirad M 2011 Daily consumption of vitamin D-or vitamin D α calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93:764-771.
347. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R 2003 The effect of vitamin D3 on insulin secre-tion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258-261.
348. Orwoll E, Riddle M, Prince M 1994 Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59:1083-1087.
349. Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS 2010 Pilot study to evaluate the effect of shortterm improvement in vitaminDstatus on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract 16: 600-608.
350. Jorde R, Figenschau Y 2009 Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48:349-354.
351. Taylor AV, Wise PH 1998 Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 74:365-366.
352. Mitri J, Muraru MD, Pittas AG 2011 Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65:1005-1015.
353. Schiaffino S 2010 Fibre types in skeletal muscle: a personal account. Acta Physiol (Oxf) 199:451-463.
354. Spangenburg EE, BoothFW2003 Molecular regulation of individual skeletal muscle fibre types. Acta Physiol Scand 178:413-424.
355. Neville PF, DeLuca HF 1966 The synthesis of [1,2-3H]vitaminD 3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. Biochemistry 5:2201-2207.
356. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF 1979 Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188-1190.
357. Boland R, NormanA, Ritz E, HasselbachW 1985 Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun 128: 305-311.
358. Sandgren ME, Brönnegärd M, DeLuca HF 1991 Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys ResCommun181:611-616.
359. Barr R, Macdonald H, Stewart A, McGuigan F, Rogers A, Eastell R, Felsenberg D, Glüer C, Roux C, Reid DM 2010 Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int 21:457-466.
360. Oh JY, Barrett-Connor E 2002 Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51:356-359.
361. Ortlepp JR, Metrikat J, Albrecht M, von Korff A, Hanrath P, Hoffmann R 2003 The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20:451-454.
362. Malecki MT, Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J 2003 Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 111:505-509.
363. Ye WZ, Reis AF, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, Velho G 2001 Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 145: 181-186.
364. Bid HK, Konwar R, Aggarwal CG, Gautam S, Saxena M, Nayak VL, Banerjee M 2009 Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci 63:187-194.
365. Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takács I, Lakatos P 2001 Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144:385-389.
366. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, Medraoe M 2008 Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 11:134-139.
367. Faulkner KA, Cauley JA, Zmuda JM, Landsittel DP, Newman AB, Studenski SA, Redfern MS, Ensrud KE, Fink HA, Lane NE, NevittMC2006 Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 17:1318-1328.
368. Verreault R, Semba RD, Volpato S, Ferrucci L, Fried LP, Guralnik JM 2002 Low serum vitamin D does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc 50:912-917.
369. Arden NK, Crozier S, Smith H, Anderson F, Edwards C, Raphael H, CooperC 2006 Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum 55:610-615.
370. Law M, Withers H, Morris J, Anderson F 2006 Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 35:482-486.
371. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ 1992 Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642.
372. ChapuyMC, Pamphile R, Paris E, KempfC, SchlichtingM, Arnaud S, Garnero P, Meunier PJ 2002 Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13:257-264.
373. Gallagher JC, Rapuri PB, Smith LM 2007 An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab 92:51-58.
374. Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm TN, Thalmann B, Stähelin HB 2004 Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 52:230-236.
375. Burleigh E, McColl J, Potter J 2007 Does vitamin D stop inpatients falling? A randomised controlled trial. Age Ageing 36:507-513.
376. Berggren M, Stenvall M, Olofsson B, Gustafson Y 2008 Evaluation of a fall-prevention program in older people after femoral neck fracture: a one-year follow-up. Osteoporos Int 19:801-809.
377. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ 2004 A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing 33:45-51.
378. Sato Y, Manabe S, Kuno H, Oizumi K 1999 Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 66:64-68.
379. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K 2005 Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-basedOPRAStudy of ElderlyWomen. Osteoporos Int 16:1425-1431.
380. Annweiler C, Beauchet O, Berrut G, Fantino B, Bonnefoy M, Herrmann FR, SchottAM2009 Is there an association between serum 25-hydroxyvitamin D concentration and muscle strength among older women? Results from baseline assessment of the EPIDOS study. J Nutr Health Aging 13:90-95.
381. Beauchet O, Annweiler C, Verghese J, Fantino B, Herrmann FR, Allali G 2011 Biology of gait control: vitamin D involvement. Neurology 76:1617-1622.
382. Mowé M, Haug E, Bøhmer T 1999 Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriatr Soc 47:220-226.
383. Brunner RL, Cochrane B, Jackson RD, Larson J, Lewis C, Limacher M, Rosal M, Shumaker S, Wallace R 2008 Calcium, vitaminDsupplementation, and physical function in the Women's Health Initiative. JAmDiet Assoc 108:1472-1479.
384. Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, Chandler J, Rosenberg E, Papanicolaou DA 2010 Once-weekly dose of 8400 IU vitamin D3 compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr 91:985-991.
385. Johnson KR, Jobber J, Stonawski BJ 1980 Prophylactic vitamin D in the elderly. Age Ageing 9:121-127.
386. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME 2010 The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 3:195-201.
387. Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA 2003 Effects of vitaminDsupplementationonstrength, physical function, and health perception in older, communitydwelling men. J Am Geriatr Soc 51:1762-1767.
388. Gupta R, Sharma U, Gupta N, Kalaivani M, Singh U, Guleria R, Jagannathan NR, GoswamiR2010 Effect of cholecalciferol and calcium supplementation on muscle strength and energy metabolism in vitamin D-deficient Asian Indians: a randomized, controlled trial. Clin Endocrinol (Oxf) 73:445-451.
389. Gloth 3rd FM, Smith CE, HollisBW, Tobin JD 1995 Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. JAmGeriatr Soc 43:1269-1271.
390. Artaza JN, Norris KC 2009 VitaminDreduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200:207-221.